We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.12%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$1.64B
(+9.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
631
New
54
Increased
195
Reduced
237
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$182M |
| 2 |
JPMorgan Chase
JPM
|
+$136M |
| 3 |
General Motors
GM
|
+$136M |
| 4 |
F5
FFIV
|
+$118M |
| 5 |
STJ
St Jude Medical
STJ
|
+$90.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$146M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
UnitedHealth
UNH
|
+$88.7M |
| 4 |
IBM
IBM
|
+$82.6M |
| 5 |
Macy's
M
|
+$74.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.51% |
| 2 | Healthcare | 16.36% |
| 3 | Technology | 15.14% |
| 4 | Industrials | 12.3% |
| 5 | Financials | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUXL
201
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $22.3M | 0.11% |
1,073,562
+79,781
| +8% | +$1.5M |
|
|
ALXN
202
DELISTED
Alexion Pharmaceuticals
ALXN
| $21.9M | 0.11% |
165,008
-19,743
| -11% | -$2.37M |
|
203
Children's Place
PLCE
$53.6M
| $21.9M | 0.11% |
384,385
-97,926
| -20% | -$5.31M |
|
204
Affiliated Managers Group
AMG
$9.46B
| $21.9M | 0.11% |
100,765
-51,625
| -34% | -$10.3M |
|
205
Stratasys
SSYS
$697M
| $21.7M | 0.11% |
+161,254
| New | +$18.6M |
|
|
GEVA
206
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $21.7M | 0.11% |
335,574
-34,304
| -9% | -$2.04M |
|
207
Prudential Financial
PRU
$41.7B
| $21.7M | 0.11% |
234,890
+33,890
| +17% | +$2.89M |
|
208
O-I Glass
OI
$1.39B
| $21.6M | 0.11% |
602,660
-42,938
| -7% | -$1.38M |
|
|
PTLA
209
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $21.4M | 0.11% |
831,334
+139,190
| +20% | +$3.38M |
|
210
Northern Oil and Gas
NOG
$2.3B
| $21.1M | 0.11% |
140,073
-37,451
| -21% | -$5.93M |
|
211
Bank of America
BAC
$435B
| $21.1M | 0.11% |
1,354,760
-2,727,603
| -67% | -$40.5M |
|
212
Lennar Class A
LEN
$20.4B
| $21.1M | 0.11% |
559,060
+276,330
| +98% | +$9.32M |
|
|
LGF
213
DELISTED
Lions Gate Entertainment
LGF
| $20.8M | 0.11% |
656,684
+70,190
| +12% | +$2.32M |
|
214
Monster Beverage
MNST
$91.4B
| $20.8M | 0.11% |
1,839,144
+1,837,584
| +117,794% | +$18.1M |
|
215
Zoetis
ZTS
$31.6B
| $20.6M | 0.1% |
629,094
+302,541
| +93% | +$9.65M |
|
|
TUP
216
DELISTED
Tupperware Brands Corporation
TUP
| $20.6M | 0.1% |
217,398
-46,602
| -18% | -$4.23M |
|
|
DCH
217
Dauch Corp
DCH
$1.3B
| $20.1M | 0.1% |
983,758
+153,876
| +19% | +$2.94M |
|
218
Liberty Global Class A
LBTYA
$3.31B
| $19.9M | 0.1% |
543,452
+154,679
| +40% | +$5.19M |
|
|
HOS
219
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $19.7M | 0.1% |
+400,839
| New | +$21.3M |
|
220
American Homes 4 Rent
AMH
$12B
| $19.4M | 0.1% |
1,194,811
+1,185,611
| +12,887% | +$19M |
|
221
Oshkosh
OSK
$9.67B
| $19.2M | 0.1% |
+380,954
| New | +$19M |
|
|
CYT
222
DELISTED
CYTEC INDS INC
CYT
| $19M | 0.1% |
408,294
-70,478
| -15% | -$3.06M |
|
223
BioMarin Pharmaceuticals
BMRN
$11.5B
| $19M | 0.1% |
270,059
+161,642
| +149% | +$11M |
|
224
ExxonMobil
XOM
$651B
| $19M | 0.1% |
187,499
+119,406
| +175% | +$11M |
|
|
BEAV
225
DELISTED
B/E Aerospace Inc
BEAV
| $18.8M | 0.1% |
298,632
-100,991
| -25% | -$6.03M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2013 Portfolio in Review
As of Q4 2013, Fred Alger Management held 631 positions worth $19.6B, up 9.1% from $18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fred Alger Management's Q4 2013 filing shows 54 new, 195 increased, 237 reduced and 53 closed positions. Its largest new stake was St Jude Medical: 1,558,402 shares worth $96.5M. The largest sale was Cadence Design Systems, an estimated $146M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.
- Fred Alger Management's largest Q4 2013 buy was St Jude Medical: 1,558,402 shares worth $96.5M.
- Fred Alger Management added most to HCA Healthcare in Q4 2013, an estimated $182M increase.
- Fred Alger Management's biggest Q4 2013 reduction was Cadence Design Systems, cutting an estimated $146M.
- Fred Alger Management fully exited Norwegian Cruise Line in Q4 2013, selling an estimated $60.6M.
- Fred Alger Management's ten largest holdings make up 20% of its $19.6B portfolio in Q4 2013.
- Fred Alger Management opened 54 new positions and closed 53 in Q4 2013.
- Fred Alger Management's portfolio value rose 9.1% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q4 2013, filed 14 Feb 2014.